Professional
Added to YB: 2026-08-06
Pitch date: 2026-08-04
EYE.AX [neutral]
Nova Eye Medical Limited
+3.57%
current return
Author Info
Company Info
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
Market Cap
AUD 39.9M
Pitch Price
AUD 0.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
-9.55
P/E
-5.48
EV/Sales
1.21
Sector
Health Care Equipment and Supplies
Category
growth
Tauranga Investments | July 2026 Update - Nova Eye Medical Limited
EYE.AX (update): Australian eye-device co nearing cashflow positive. FY27 guide: 15-37% sales growth ex-China + positive EBITDA, easing capital-raise risk. Cash burn fell from $2.5m H1 to $1.5m H2. $964k cash + $2.75m credit facility may fund breakeven. ~4% US mild/moderate glaucoma share, upside if grows.
Read full article (1 min)